NetworkNewsBreaks – ABcann Global Corp. (TSX.V:
Post# of 111
(Total Views: 305)
Posted On: 03/06/2018 6:05:06 PM
NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Posts Business Update
ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning released an update regarding the company’s recent achievements and plans moving forward. Per the update, the company intends to use its recent financing of $75 million, which brought the company’s cash to over $135 million, to accelerate its growth through a disciplined capital allocation process. Abcann intends to expand its production capacity, focus on branding and product innovation, expand its Harvest Medicine platform to new locations and develop strategic partnerships in the industry. “Over the past five months we have enhanced our leadership team, strengthened our balance sheet, improved operational effectiveness and executed a strategic acquisition. Last week, after completing an extensive strategic review of our operations and growth plans, our board of directors approved our 2018 Business Plan, and the ABcann team is now sharply focused on execution,” ABcann Global CEO Barry Fishman stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning released an update regarding the company’s recent achievements and plans moving forward. Per the update, the company intends to use its recent financing of $75 million, which brought the company’s cash to over $135 million, to accelerate its growth through a disciplined capital allocation process. Abcann intends to expand its production capacity, focus on branding and product innovation, expand its Harvest Medicine platform to new locations and develop strategic partnerships in the industry. “Over the past five months we have enhanced our leadership team, strengthened our balance sheet, improved operational effectiveness and executed a strategic acquisition. Last week, after completing an extensive strategic review of our operations and growth plans, our board of directors approved our 2018 Business Plan, and the ABcann team is now sharply focused on execution,” ABcann Global CEO Barry Fishman stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)